Takeda Pharmaceutical Co. Ltd.

In News

Takeda Pharmaceutical Co Ltd (BSP:TAKP34) Bonds - GuruFocus

GuruFocus - Apr 16, 2026

Takeda's Next Chapter: CEO Insights on Innovation & Growth - Takeda Pharmaceuticals

Takeda Pharmaceuticals - Dec 22, 2025

Takeda Pharmaceutical Company: Three high-potential launches and a strong pipeline position the company for sustained growth - TradingView

TradingView - Jan 12, 2026

US FDA investigates Takeda's blood disorder drug after pediatric death - Reuters

Reuters - Nov 21, 2025

Takeda Pharmaceutical Company Limited (TSE:4502) Goes Ex-Dividend Soon - simplywall.st

simplywall.st - Mar 27, 2026

Takeda (NYSE: TAK) PDT unit president reports 84,787 ADS and RSU stake - Stock Titan

Stock Titan - Apr 06, 2026

Takeda Pharmaceutical Company L (TAK) Stock Analysis: Unlocking 15% Upside Potential - DirectorsTalk Interviews

DirectorsTalk Interviews - Apr 20, 2026

Innovent rings up $11.4B deal with Takeda for three I-O/ADC assets - BioWorld News

BioWorld News - Oct 22, 2025

Takeda Unit Defends Bowel Disease Drug Patent In UK - Law360

Law360 - Apr 14, 2026

Takeda inks $1.7B AI discovery deal with Iambic Therapeutics - Fierce Biotech

Fierce Biotech - Feb 09, 2026

Takeda: Lack Of Realistic Upside In Japanese Pharma (NYSE:TAK) - Seeking Alpha

Seeking Alpha - Dec 11, 2025

Takeda 2024 Annual Integrated Report | Better Health for People, Brighter Future for the World - Takeda Pharmaceuticals

Takeda Pharmaceuticals - Jun 30, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment